רפלגל
takeda israel ltd - agalsidase alfa - תרכיז להכנת תמיסה לאינפוזיה - agalsidase alfa 1 mg/ml - agalsidase alfa - agalsidase alfa - replagal is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease (alfa-galactosidase a deficiency).
ויפריב 400
takeda israel ltd - velaglucerase alfa - lyophilized powder for infusion - velaglucerase alfa 400 u/vial - velaglucerase alfa - velaglucerase alfa - vpriv is a hydrolytic glucocerebroside – specific enzyme indicated for the long term replacement therapy (ert) for pediatric and adult patients with type 1 gaucher disease.
המופיל אם פקטור נגד המופיליה (הומני) שיטה אם מונוקלונלי מטוהר
takeda israel ltd - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 220 - 2000 iu/vial - coagulation factor viii - coagulation factor viii - hemophilia a - for the prevention and control of hemorrhagic episodes
אדוייט iu 500
takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - אבקה להכנת תמיסה לזריקה - octocog alfa (antihemophilic factor recombinant) 500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).
אדוייט iu 1000
takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - אבקה להכנת תמיסה לזריקה - octocog alfa (antihemophilic factor recombinant) 1000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).
אדוייט iu 1500
takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - אבקה להכנת תמיסה לזריקה - octocog alfa (antihemophilic factor recombinant) 1500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).
אדוייט iu 2000
takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - אבקה להכנת תמיסה לזריקה - octocog alfa (antihemophilic factor recombinant) 2000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).
אדוייט iu 3000
takeda israel ltd - octocog alfa (antihemophilic factor recombinant) - אבקה להכנת תמיסה לזריקה - octocog alfa (antihemophilic factor recombinant) 3000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).
פייבה 500 יחידות
takeda israel ltd - factor viii inhibitor bypassing fraction - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - factor viii inhibitor bypassing fraction 500 u/vial - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - for the control of bleeding episodes in haemophilia a patients with factor viii inhibitors and also in patients with acquired factor viii inhibitors.
פירזיר 30 מג
takeda israel ltd - icatibant as acetate - תמיסה להזרקה - icatibant as acetate 30 mg / 3 ml - icatibant - icatibant - symptomatic treatment of acute attacks of hereditary angioedima (hae) in adults (with c1 -esterase-inhibitor deficiency).